Authors

Simon Cohen

Partner

Read More

Colin McCall

Partner

Read More

Paul England, DPhil

Senior professional support lawyer

Read More

Tasmina Goraya, PhD

Partner

Read More

Dr. Anja Lunze, LL.M.

Partner

Read More

Michael Washbrook

Senior counsel

Read More
Authors

Simon Cohen

Partner

Read More

Colin McCall

Partner

Read More

Paul England, DPhil

Senior professional support lawyer

Read More

Tasmina Goraya, PhD

Partner

Read More

Dr. Anja Lunze, LL.M.

Partner

Read More

Michael Washbrook

Senior counsel

Read More

28 June 2019

Synapse

This month on Synapse

The Treatment

Written by a team of Taylor Wessing's legal experts, The Treatment is designed to provide a high level overview of some of the most important issues to consider for any life sciences company seeking these opportunities by coming to Europe.

Webinar: Recent legislative developments affecting biologics and biosimilars

Session 2 of our 2019 biosimilars webinars series focuses on key factors decision makers need to be aware of when considering currently pending legislation.

SPC manufacturing waiver for export and stockpiling comes into force

Michael Washbrook provides an overview of the new SPC manufacturing waiver for export and stockpiling that will come into force on 1 July 2019.

No compulsory licence for Sanofi's Praluent in Germany

Dr Anja Lunze explores the decision of the German Federal Supreme Court to refuse Sanofi’s request for a preliminary compulsory licence regarding Amgen’s patent relating to antigen binding proteins against PCSK9.

Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

Life sciences & healthcare

Synapse - January 2020

16 January 2020

by multiple authors

Click here to find out more
Life sciences & healthcare

Synapse - December 2019

19 December 2019

by multiple authors

Click here to find out more
Life sciences & healthcare

Synapse - November 2019

26 November 2019

by multiple authors

Click here to find out more